Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
Clinical trial NCT02101853 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02101853
- Sponsor
- National Cancer Institute (NCI)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-17
- Primary completion
- 2021-06-30
- Enrollment
- 669
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.